LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 269 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 1.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $2,150,528 | +5.1% | 30,111 | -11.9% | 0.25% | -3.1% |
| Q3 2023 | $2,046,867 | -39.3% | 34,160 | -27.0% | 0.26% | -35.4% |
| Q2 2023 | $3,373,919 | -12.8% | 46,795 | -11.0% | 0.40% | -19.3% |
| Q1 2023 | $3,869,550 | +5.3% | 52,604 | -4.4% | 0.49% | +1.0% |
| Q4 2022 | $3,674,935 | -30.8% | 55,014 | -10.8% | 0.49% | -38.2% |
| Q3 2022 | $5,312,000 | -6.8% | 61,694 | -3.5% | 0.79% | -0.1% |
| Q2 2022 | $5,701,000 | -20.9% | 63,900 | -0.2% | 0.79% | -6.3% |
| Q1 2022 | $7,205,000 | -32.1% | 64,050 | -6.7% | 0.84% | -24.0% |
| Q4 2021 | $10,606,000 | +10.9% | 68,666 | 0.0% | 1.11% | -0.4% |
| Q3 2021 | $9,567,000 | +6.0% | 68,666 | -0.2% | 1.12% | +5.1% |
| Q2 2021 | $9,023,000 | -13.9% | 68,776 | 0.0% | 1.06% | -20.3% |
| Q1 2021 | $10,485,000 | +51.7% | 68,776 | -1.0% | 1.33% | +44.1% |
| Q4 2020 | $6,910,000 | +4.4% | 69,483 | +0.0% | 0.92% | -13.5% |
| Q3 2020 | $6,621,000 | -16.5% | 69,463 | -2.1% | 1.07% | -20.9% |
| Q2 2020 | $7,933,000 | +54.0% | 70,923 | +0.1% | 1.35% | +28.9% |
| Q1 2020 | $5,150,000 | -30.9% | 70,817 | -0.9% | 1.05% | -13.6% |
| Q4 2019 | $7,456,000 | +5.1% | 71,489 | +0.3% | 1.21% | -1.8% |
| Q3 2019 | $7,092,000 | -12.7% | 71,248 | +0.1% | 1.24% | -12.9% |
| Q2 2019 | $8,126,000 | -8.6% | 71,183 | +0.6% | 1.42% | -10.9% |
| Q1 2019 | $8,894,000 | -6.0% | 70,753 | +1.4% | 1.59% | -16.2% |
| Q4 2018 | $9,466,000 | -48.3% | 69,759 | +4.6% | 1.90% | -38.6% |
| Q3 2018 | $18,311,000 | +30.2% | 66,708 | -1.7% | 3.10% | +19.5% |
| Q2 2018 | $14,066,000 | +23.5% | 67,896 | -1.6% | 2.59% | +20.2% |
| Q1 2018 | $11,391,000 | +20.3% | 68,971 | -0.3% | 2.15% | +23.4% |
| Q4 2017 | $9,468,000 | +0.9% | 69,148 | +0.3% | 1.75% | -2.4% |
| Q3 2017 | $9,386,000 | +13.4% | 68,935 | +1.1% | 1.79% | +10.2% |
| Q2 2017 | $8,280,000 | +16.9% | 68,205 | +1.9% | 1.62% | +13.7% |
| Q1 2017 | $7,082,000 | +5.1% | 66,915 | +0.9% | 1.43% | +4.5% |
| Q4 2016 | $6,736,000 | -1.7% | 66,289 | -1.3% | 1.37% | -2.6% |
| Q3 2016 | $6,853,000 | -16.8% | 67,145 | -2.7% | 1.40% | -17.5% |
| Q2 2016 | $8,234,000 | +10.8% | 69,038 | -0.5% | 1.70% | +8.8% |
| Q1 2016 | $7,432,000 | -1.2% | 69,398 | 0.0% | 1.56% | -5.5% |
| Q4 2015 | $7,524,000 | +25.2% | 69,398 | -1.1% | 1.65% | +20.9% |
| Q3 2015 | $6,008,000 | -16.7% | 70,143 | -1.8% | 1.37% | +0.7% |
| Q2 2015 | $7,209,000 | +31.4% | 71,443 | +0.4% | 1.36% | +33.4% |
| Q1 2015 | $5,487,000 | +75.1% | 71,163 | +20.9% | 1.02% | +74.9% |
| Q4 2014 | $3,133,000 | +27.7% | 58,883 | +12.7% | 0.58% | +23.3% |
| Q3 2014 | $2,454,000 | +5.3% | 52,228 | +39.6% | 0.47% | +14.3% |
| Q2 2014 | $2,330,000 | +32.5% | 37,403 | +43.1% | 0.41% | +26.3% |
| Q1 2014 | $1,759,000 | +279.1% | 26,143 | +196.1% | 0.33% | +289.3% |
| Q4 2013 | $464,000 | – | 8,829 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $12,937,000 | 4.12% |
| Stonepine Capital Management, LLC | 73,700 | $8,291,000 | 3.44% |
| VILLERE ST DENIS J & CO LLC | 510,843 | $57,464,000 | 3.41% |
| Chicago Capital, LLC | 491,717 | $55,313,000 | 2.38% |
| Orchard Capital Management, LLC | 73,596 | $8,279,000 | 2.35% |
| RICE HALL JAMES & ASSOCIATES, LLC | 344,969 | $38,806,000 | 1.55% |
| Smith, Graham & Co., Investment Advisors, LP | 86,834 | $9,768,000 | 1.02% |
| WOODSTOCK CORP | 64,050 | $7,205,000 | 0.84% |
| INVESTMENT MANAGEMENT OF VIRGINIA LLC | 37,246 | $4,190,000 | 0.74% |
| Stephens Investment Management Group LLC | 417,670 | $46,984,000 | 0.69% |